Loss of Ran expression in the TOV112D-Tet-shRan xenograft-based model showed a dramatic delay in tumor growth as exemplified by a significant decrease in tumor volume (Fig. 6A) and weight (Supplementary Fig. S6B). Here, RAN is linked to neoplasm.